Mary Ann Adelfio, M.D Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 116 Kraft Ave, Bronxville, NY 10708 Phone: 914-337-7711 Fax: 631-878-4280 |
News Archive
Ardea Biosciences, Inc. announced additional positive results from the completed first cohort of an ongoing Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout.
A number of clinical symptoms and signs are included under the broad group Rosacea. Facial flushing, the appearance of broken blood vessels and persistent redness of the face, eruption of inflamed spots & pimples, on the face and thickening of the sebaceous glands of the nose, with swelling & congestion in that area.
The biggest killer of women over the age of 50 is heart disease. By age 65 women have the same heart attack or stroke risk as men and a greater risk of dying from either. To help better predict heart attack risk in these women, Atherotech Diagnostics Lab has developed a new and better way to test for heart disease risk. The new test will soon be available exclusively through Atherotech Diagnostics Lab.
ImaginAb, and Eurogentec S.A. announce a development collaboration to establish a novel system for producing engineered antibody fragments. The two companies will produce ImaginAb's optimized antibody fragments with Eurogentec's high-performance Pichia pastoris expression system.
Loyola University Health System will open an acupuncture clinic for men and women with pelvic health disorders this fall. The clinic will use acupuncture to treat patients with common conditions such as pelvic pain, nausea from pelvic surgery, interstitial cystitis, painful bladder syndrome, postoperative pain, prostatitis and overactive bladder.
› Verified 3 days ago